Work

Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival

Year: 2016

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: JNCI Journal of the National Cancer Institute

DOI: 10.1093/jnci/djw279

Authors: Chee Khoon Lee, Lucy Davies, Yi-Long Wu, Tetsuya Mitsudomi, Akira Inoue, Rafael Rosell, Caicun Zhou, Kazuhiko Nakagawa, Sumitra Thongprasert, Masahiro Fukuoka, Sally Lord, Ian Marschner, Yu-Kang Tu, Richard J. Gralla, Val Gebski, Tony Mok, James Chih-Hsin Yang

Institutions: The University of Sydney, St George Hospital, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Chinese University of Hong Kong, Kindai University, Tohoku University, Institut Català d'Oncologia, Tongji University, Shanghai Pulmonary Hospital, Chiang Mai University, The University of Notre Dame Australia, Macquarie University, National Taiwan University, Albert Einstein College of Medicine, Jacobi Medical Center, National Taiwan University Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2607954371

FWCI: 4.158

Cites: 26

Cited by: 252

Related to: 10